Call End: Ultragenyx Pharmaceutical, Inc. (NASDAQ:RARE) Q4 2023 Earnings Conference Call February 15, 2024, 05:00 PM ET Company Participants Joshua Higa - Vice President of Investor Relations Emil Kakkis - Chief Executive Officer & President Erik Harris - Chief Commercial Officer Howard Horn - Chief Financial Officer Eric Crombez - Chief Medical Officer Conference Call Participants Gena Wang - Barclays Maurice Raycroft - Jefferies Anupam Rama - JPMorgan Tazeen Ahmad - Bank of America Dae Gon Ha - Stifel Meh ...